MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

Search

Microbot Medical Inc

Închisă

2.58 -2.27

Rezumat

Modificarea prețului

24h

Curent

Minim

2.56

Maxim

2.72

Indicatori cheie

By Trading Economics

Venit

791K

-2.6M

Angajați

20

EBITDA

-127K

-3.4M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+240.91% upside

Dividende

By Dow Jones

Următoarele câștiguri

12 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

2.5M

95M

Deschiderea anterioară

4.85

Închiderea anterioară

2.58

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Microbot Medical Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

11 iul. 2025, 22:19 UTC

Achiziții, Fuziuni, Preluări

FCC Approves U.S. Cellular Sale to T-Mobile

11 iul. 2025, 17:28 UTC

Principalele dinamici ale pieței

SharpLink Gaming Gains on Ethereum Purchase

11 iul. 2025, 16:57 UTC

Câștiguri

BASF Cuts Outlook on Global Economy Uncertainty

11 iul. 2025, 21:45 UTC

Market Talk

Fitch Affirms Germany's Rating, Sees Deficit, Debt Rising -- Market Talk

11 iul. 2025, 19:46 UTC

Achiziții, Fuziuni, Preluări

Kraft Heinz Might Split Up, Report Says. What Investors Need to Know. -- Barrons.com

11 iul. 2025, 19:45 UTC

Market Talk

Crude Futures Post Back-to-Back Weekly Gains -- Market Talk

11 iul. 2025, 19:05 UTC

Market Talk

U.S. Natural Gas Futures Post Third Straight Weekly Loss -- Market Talk

11 iul. 2025, 18:18 UTC

Market Talk

Canada Officials Tight-Lipped on Next Steps in Trump Trade Talks -- Market Talk

11 iul. 2025, 17:35 UTC

Market Talk

Canada Should Target Lower Sectoral Tariffs, Import Quotas in US Trade Talks -- Market Talk

11 iul. 2025, 17:26 UTC

Market Talk

U.S. Oil Rig Count Down by 1 to 424 -- Market Talk

11 iul. 2025, 16:53 UTC

Market Talk

Crude Futures Add to Early Gains -- Market Talk

11 iul. 2025, 16:42 UTC

Câștiguri

BASF Cuts Outlook on Global Economic Uncertainty

11 iul. 2025, 16:08 UTC

Market Talk

Rise in Canadian Staycations May Help Explain Labor Market Strength -- Market Talk

11 iul. 2025, 16:05 UTC

Câștiguri

BASF Will Publish Half-Year Results on July 30

11 iul. 2025, 16:04 UTC

Market Talk

Global Equities Roundup: Market Talk

11 iul. 2025, 16:04 UTC

Market Talk

Senior Housing Shortage Gives REITs Pricing Power -- Market Talk

11 iul. 2025, 16:03 UTC

Câștiguri

BASF: Guidance Cut Is Due to Ongoing Macroeconomic, Geopolitical Uncertainties

11 iul. 2025, 16:02 UTC

Câștiguri

BASF Continues to Expect Free Cash Flow Between EUR400M and EUR800M in 2025

11 iul. 2025, 16:01 UTC

Câștiguri

BASF Had Seen Ebitda Before Special Items Between EUR8B and EUR8.4B in 2025

11 iul. 2025, 16:00 UTC

Câștiguri

BASF Now Sees Ebitda Before Special Items Between EUR7.3B and EUR7.7B in 2025

11 iul. 2025, 15:59 UTC

Câștiguri

BASF Cuts 2025 Earnings View

11 iul. 2025, 15:58 UTC

Câștiguri

Nvidia's CEO Has Sold a Million Shares. He Has Millions More to Sell. -- Barrons.com

11 iul. 2025, 15:57 UTC

Câștiguri

BASF 2Q EBIT Before Special Items EUR810M

11 iul. 2025, 15:54 UTC

Câștiguri

BASF: Analysts Had Expected 2Q Sales of EUR15.80B

11 iul. 2025, 15:54 UTC

Câștiguri

BASF 2Q Sales Fell 2.1% on Year

11 iul. 2025, 15:53 UTC

Câștiguri

BASF 2Q Sales EUR15.77B

11 iul. 2025, 15:52 UTC

Câștiguri

BASF: This Was in Line With Consensus Estimates

11 iul. 2025, 15:52 UTC

Câștiguri

BASF 2Q Ebitda Before Special Items EUR1.77B

11 iul. 2025, 15:49 UTC

Câștiguri

BASF Reports Preliminary 2Q Figures, Adjusts 2025 Outlook

11 iul. 2025, 15:41 UTC

Market Talk

Oil, Gas Prices Not Seen Supporting Drilling Boom -- Market Talk

Comparație

Modificare preț

Microbot Medical Inc Așteptări

Obiectiv de preț

By TipRanks

240.91% sus

Prognoză pe 12 luni

Medie 9 USD  240.91%

Maxim 9 USD

Minim 9 USD

În baza a 1 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruMicrobot Medical Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

1 ratings

1

Cumpărare

0

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

2.52 / 2.57Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Very Strong Bullish Evidence

Termen lung

Weak Bullish Evidence

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.